New trends, such
as inhalative
sedation or
ketamine, are
beginning
to garner
moreattention
References
1 Oddo M et al. Optimizing
sedation in patients with
acute brain injury. Critical Care
2016;20:128.
2 Badenes R, De Fez M. Sedation
in neurocritical units. In Khan
Z (ed): Challenging Topics in
Neuroanesthesia and Neurocritical
Care. Springer International
Publishing Switzerland 2017;
259–74.
3 Brummel NE, Girard. TD.
Preventing delirium in the
intensive care unit. Crit Care Clin
2013:29:51–65.
4 Otterspoor LC, Kalkman CJ,
Cremer OL. Update on the
propofol infusión syndrome in
ICU management on patients
with head injury. Curr Opin
Anaesthesiol 2008;21:544–51.
5 Smith HA et al. Delirium:
an emerging frontier in the
management of critically
ill children. Crit Care Clin
2009;25:593–614.
6 Kress JP et al. Daily interruption
of sedative infusions in critically ill
patients undergoing mechanical
ventilation. N Engl J Med
2000;342:1471–7.
7 Hogarth DK, Hall J. Management
of sedation in mechanically
ventilated patients. Curr Opin Crit
Care 2004;10:40–6.
8 DeJonge B et al. Using and
understanding sedation scoring
systems: a systematic review.
Intensive Care Med 2000;26:
275–86.
9 Schnakers C et al. The
Nociception Coma Scale: a new
tool to assess nociception in
disorders of consciousness. Pain
2010;148:215–9.
10 Riess ML et al. Sedation
assessment in critically ill patients
with bispectral index. Eur J
Anesthesiol 2002;19:18–22.
11 Deogaonkar A et al. Bispectral
index monitoring correlates
with sedation scales in brain-
injured patients. Crit Care Med
2004;32:2403–6.
12 Ogilvie MP, Pereire BM, Ryan
ML, et al. Bispectral index to
monitor propofol sedation
in trauma patients. J Trauma
2011;71:1415–21.
13 Skoglund K et al. The
neurological wake up test
increases stress hormone levels
in patients with severe traumatic
brain injury. Crit Care Med
2012;40:216–22.
14 Burry L et al. Daily sedation
interruption versus no daily
sedation interruption for critically
ill adults patients requi ring
invasive mechanical ventilation.
Cochrane Database Syst Rev
2014;7:CD009176.
15 Heibok R et al. Effects of the
neurological wake-up test on
clinical examination, intrancranial
pressure, brain metabolism
and brain tissue oxygenation in
severely brain-injured patients.
Crit Care 2012;16:R226.
16 Penson RT et al. Randomized
placebo-controlled trial to
the activity of the morphine
glucuronides. Clin Pharmacol Ther
2000;68:667–76.
17 Ickx B et al. Propofol infusion
for induction and maintenance of
anaesthesia in patients with end-
stage real disease. Br J Anaesth
1998;81:854–60.
18 Hiraoka H et al. Changes in
drug plasma concentrations
of an extensively bound and
highly extracted drug, propofol,
in response to altered plasma
binding. Clin Pharmacol Ther
2004;75:324–30.
19 Servin F et al. Pharmacokinetics
of propofol administered by
continuous infusion in patients
with cirrosis. Preliminary results.
Anaesthesia 1988;43:23–4.
20 Pentikainen PJ et al.
Pharmacokinetics of midazolam
following intravenous and oral
administration in patients with
chronic liver disease and in
healthy subjects. J Clin Pharmacol
1989;29:272–7.
21 Chauvin M et al. Sufentanil
pharmacokinetics in patients
with cirrhosis. Anesth Analg
1989;68:1–4.
22 Mazoit JX et al.
Pharmacokinetics of unchanged
morphine in normal and
cirrhotic subjects. Anesth Analg
1987;66:296–8.
23 Skoglund K, Enblad P, Marklund
N. Effects of the neurological wake
up test in intracranial pressure
and cerebral perfusion pressure in
brain injured patients. Neurocrit
Care 2009;11:135–42.
24 Citerio G, Cormio M. Sedation
in neurointensive care: advances
in understanding and practice.
Curr Opin Crit Care 2003;9:120–6.
25 Barr J et al. Propofol
dosing regimens for ICU
sedation based upon an
integrated pharmacikenetic-
pharmacodynamic model.
Anesthesiology 2001;95:324–33.
26 Oshima T, Karasawa F, Satoh
T. Effects of propofol on cerebral
blood flow and the metabolic
rate of oxygen in humans. Acta
Anesthesiol Scand 2002;46:831–5.
27 Engelhard K, Werner C.
Inhalational or intravenous
anesthetics for craniotomies?
Pro inhalational. Curr Opin
Anaesthesiol 2006;19:504–8.
28 Trescot AM et al. Opioid
pharmacology. Pain Physicia
2008;11: S133–53.
29 Weinbroum AA et al.
Midazolam versus propofol
for long-term sedation in the
ICU: a randomized prospective
comparison. Intensive Care Med
1997;23:1258–63.
30 Power KN et al. Propofol
treatment in adult refractory
status epilecpticus. Mortality
risk and outcome. Epilepsy Res
2011;94:53–60.
31 Meierkord H et al. European
Federation of Neurological
Societies. EFNS guideline on
the management of status
epilepticus in adults. Eur J Neurol
2010;17:348–55.
32 Marik PE, Varon J. The
management of status epilepticus.
Chest 2004;126:582–91.
33 Ebert TJ et al. Sympathetic
responses to induction of
anesthesia in humans with
propofol or etomidate.
Anesthesiology1992;76:725–33.
34 Gonzalez-Correa JA et al.
Effects of propofol on the
leukocyte nitric oxide pathway: in
vitro and ex vivo studies in surgical
patients. Naunyn Schmiedeberg’s
Arch Pharmacol 2008;376:331–9.
35 Dorsout MF et al. Role of
propofol and its solvent, intralipid,
in nitric oxide induced peripherial
vasodilation in dogs. Br J Anesth
2002;89:492–8.
36 Samain E et al. The effect
of propofol on angiotensin
II-induced Ca 2(+) mobilization
in aortic smooth muscle
cells from normotensive and
hypertensive rats. Anesth Analg
2009;90:546–52.
37 Hutchens MP, Memtsoudis
S, Sadovnikoff N. Propofol for
sedation in neurointensive care.
Neurocrit Care 2006;4:54–62.
38 Roberts DJ et al. Sedation
for critically ill adults with
severe traumatic brain injury: a
systematic review of randomized
13
HHE 2018 | hospitalhealthcare.com
controlled trials. Cric Care Med
2011;39:2743–51.
39 Peeters MY et al. Diseases
severity is a major determinant
for the pharmacodynamics
of propofol in critically ill
patients. Clin Pharmacol Ther
2008;83:443–51.
40 Karabinis A et al. Safety and
efficacy of analgesia-based
sedation with remifentanil versus
standard hypotic-based regimens
in intesive care patients with brain
injuries: a randomised, controlled
trial. Crit Care 2004;8:R268–80.
41 Hanley DF, Pozo M. Treatment
of status epilepticus with
midazolam in the critical care
setting. Int J Clin Pract 2000;54:
30–5.
42 Walder B, Tramer MR, Seeck
M. Seizure-like phenomena and
propofol : a systematic review.
Neurology 2002;58:1327–32.
43 Bauer TM et al. Prolonged
sedation due to accumulation
of conjugated metabolites of
midazolam. Lancet 1995;346:
145–7.
44 Grof TM, Bledsoe KA. Evaluating
the use of dexmedetomidine
in neurocritical care patients.
Neurocrit Care 2010;12:356–61.
45 Chen HI et al. Barbiturate
infusion for intractable intracranial
hypertension and its effect on
brain oxygenation. Neurosurgery
2008;63:880–6.
46 Marshall GT et al. Pentobarbital
come for refractory intra-cranial
hypertension after severe
traumatic brain injury: mortality
predictions and one-year
outcomes in 55 patients. J Trauma
2010;69:275–83.
47 Yahwak JA et al. Determination
of a lorazepam dose threshold for
using the osmol gap to monitor
the propylene glycol toxicity.
Pharmacotherapy 2008;28:984–91.
48 Jakob SM et al.
Dexmedetomidine vs. midazolam
or propofol for sedation during
prolonged mechanical ventilation:
two randomized controlled trials.
JAMA 2012;307:1151–60.
49 Erdman M et al. A comparison
of severe hemodynamic
disturbances between
dexmedetomidine and propofol
for sedation in neurocritical
care patients. Crit Care Med
2014;42(7):1696–702.
50 Riker RR et al. SEDCOM (Safety
and Efficacy of Dexmedetomidine
Compared with Midazolam)
Study Group: Dexmedetomidine
vs. midazolam for sedation of
critically ill patients: a randomized
trial. JAMA 2009;301:489–99.
51 Jakob SM et al.
Dexmedetomidine for long-
term sedation investigators:
Dexmedetomidine vs. midazolam
or propofol for sedation during
prolonged mechanical ventilation:
two randomized controlled trials.
JAMA 2012;307:1151–60.
52 Martin J et al. Evidence and
consensus-based German
guidelines for the management of
analgesia, sedation and de lirium
in intensive care-short versión. Ger
Med Sci 2010:8;Doc02.
53 Millane TA, Bennet E, Grounds
RM. Isoflurane and propofol
for long-term sedation in the
intensive care unit a crossover
study. Anaesthesia 1992;47:
768–74.
54 Spencer EM, Willats SM.
Isoflurane for prolonged sedation
in the intensive care unit: efficacy
and safety. Intensive Care Med
1992;18:415–21.
55 Meiser A et al. Desflurane
compared with propofol for
postoperative sedation in the
intensive care unit. Br J Anaesth
2003;90:273–80.
56 Halpenny D. Sevoflurane
sedation. Can J Anaesth
2000;47:193–4.
57 Ibrahim AE et al. Speed of
recovery and side-effect profile of
sevoflurane sedation compared
with midazolam. Anesthesiology
2001;94:87–94.
58 Kong KL, Willats SM, Prys-
Roberts C. Isoflurane compared
with midazolam for sedation
in the intensive care unti. BMJ
1989:298:1277–80.
59 Kalenka A, Gross B, Isoflurane
MH. Anesthesia elicits protein
pattern changes in rat
hippocampus. J Neurosurg
Anesthesiol 2010;22:144–54.
60 Tanzi RE, Bertram L. Twenty
years of the Alzheimer´s disease
amyloid hypothesis: a genetic
perspective. Cell 2005;120:545–55.
61 Selkoe DJ. Alzheimer`s disease:
genes, proteins and therapy.
Physiol Rev 2001;81:741–66.
62 Eckenhoff RG et al. Inhaled
anesthetic enhancement of
amyloid-beta oligomerization
and cytotoxicity. Anesthesiology
2004;101:703–9.
63 Xie Z et al. The common
inhalation anesthetic isoflurane
induces apoptosis and increases
amyloid beta protein levels.
Anesthesiology 2006;104:988–94.
64 Lee JJ, Li L, Jung HH, Zuo Z.
Postconditioning with isoflurane
reduced ischemia-induced brain
injury in rats. Anesthesiology
2008;108:1055–62.
65 Xie Z et al. The inhalation
anesthetic isoflurane induces
a vicious cycle of apoptosis
and amyloid beta-protein
accumulation. J Neurosci
2007;27:1247–54.
66 Purruker JC, Renzland J,
Uhlmann L. Volatile sedation
with sevoflurane in intensive
care patients with acute stroke or
subarachnoid haemorrhage using
AnaConDa®: an observational
study. Br J Anaesth 2015;114:
934–43.
67 White PF, Way WL, Trevor AJ.
Ketamine – its pharmacology and
therapeutic uses. Anesthesiology
1982;56:119–36.
68 Zeiler FA et al. The ketamine
effect on intracranieal pressure in
nontraumatic neurological illness.
J Crit Care 2014;29:1096–106.
69 Himmelseher S, Durieux ME.
Revising a dogma: ketamine for
patients with neurological injury?
Anesth Analg 2005;101:524–34.